Family Medicine · Pismo Beach, CA
NPI
1609867738
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
575 Price St, Suite 101
Pismo Beach, CA, 93449
Phone (805) 773-0707
Groups this clinician bills Medicare through
Medicare paid, 2024
$247K
3,538 services
Medicare patients, 2024
407
Average age 72
Drug cost, 2024
$1.1M
7,297 prescriptions
Company payments, 2025
$2,344
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wendy E Weiss was code 99214 (office e&m - established), 1,024 times for 341 patients. In total Wendy E Weiss billed 3,538 services in 50 codes, and Medicare paid $247K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,024 | 341 | $91.30 | $93K |
| J0897 Injection, denosumab, 1 mg | Office | 426 | 60 | $17.45 | $7,435 |
| 99349 Home E&M - New and Established | Office | 392 | 83 | $83.62 | $33K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 242 | 242 | $19.73 | $4,774 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 240 | 240 | $131.66 | $32K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 237 | 237 | $19.73 | $4,676 |
| G0008 Administration of influenza virus vaccine | Office | 180 | 177 | $33.49 | $6,028 |
| 90653 Vaccine Product | Office | 129 | 129 | $81.19 | $10K |
| 96372 Injection Administration | Office | 119 | 68 | $10.72 | $1,276 |
| 99215 Office E&M - Established | Office | 102 | 88 | $126.41 | $13K |
| 99350 Home E&M - New and Established | Office | 52 | 46 | $142.08 | $7,388 |
| 93000 Electrocardiogram | Office | 49 | 43 | $10.91 | $534 |
| 99205 Office E&M - New | Office | 46 | 46 | $136.30 | $6,270 |
| 90656 Vaccine Product | Office | 45 | 45 | $21.90 | $986 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 42 | 31 | $225.72 | $9,480 |
By year: 2022 $182K for 7,267 services; 2023 $221K for 3,354 services; 2024 $247K for 3,538 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 19 | 16 | $3.41 | $64.79 |
Medicare prescription drug claims, 2024
In 2024, the drug Wendy E Weiss prescribed most often to Medicare patients was Atorvastatin Calcium, with 347 prescriptions and refills. In total Wendy E Weiss wrote 7,297 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 347 | 655 | 88 | $4,959 |
| Lactulose Generic | 330 | 337 | 50 | $17K |
| Levothyroxine Sodium Generic | 276 | 449 | 62 | $3,697 |
| Omeprazole Generic | 206 | 293 | 35 | $2,977 |
| Synthroid Levothyroxine Sodium | 204 | 226 | 21 | $11K |
| Lisinopril Generic | 185 | 381 | 48 | $1,664 |
| Sertraline Hcl Generic | 176 | 229 | 25 | $3,851 |
| Levetiracetam Generic | 168 | 171 | 14 | $20K |
| Gabapentin Generic | 131 | 180 | 23 | $3,323 |
| Prolia Denosumab | 103 | 583 | 67 | $179K |
| Tamsulosin Hcl Generic | 101 | 131 | 17 | $2,709 |
| Levoxyl Levothyroxine Sodium | 101 | 113 | 11 | $2,896 |
| Metoprolol Succinate Generic | 98 | 216 | 27 | $2,121 |
| Linzess Linaclotide | 96 | 98 | Under 11 | $55K |
| Metformin Hcl Generic | 91 | 150 | 20 | $1,082 |
Brand drugs: 1,544 claims; generic drugs: 5,685 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wendy E Weiss $2,344 ($2,344 in general payments such as food, travel and fees) from 23 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $316.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.